RATIONALE: Overproduction of mucus is a contributory factor in the progression of chronic obstructive pulmonary disease (COPD). The polymeric mucins are major macromolecules in the secretion. Therefore, we hypothesized that the polymeric mucin composition or properties may be different in the sputum from individuals with COPD and smokers without airflow obstruction. OBJECTIVES: To determine the major polymeric mucins in COPD sputum and whether these are different in the sputum from individuals with COPD compared with that from smokers without airflow obstruction. METHODS: The polymeric mucin composition of sputum from patients with COPD and smokers without airflow obstruction was analyzed by Western blotting analysis. The tissue localization of the mucins was determined by immunohistochemistry, and their size distribution was analyzed by rate-zonal centrifugation. MEASUREMENTS AND MAIN RESULTS: MUC5AC and MUC5B were the major mucins. MUC5AC was the predominant mucin in the smoker group, whereas MUC5B was more abundant from the patients with COPD, with a significant difference in the ratio of MUC5B to MUC5AC (P = 0.004); this ratio was correlated with FEV(1) in the COPD group (r = 0.63; P = 0.01). The lower-charged glycosylated form of MUC5B was more predominant in COPD (P = 0.012). No significant associations were observed with respect to sex, age, or pack-year history. In both groups, MUC5AC was produced by surface epithelial cells and MUC5B by submucosal gland cells. Finally, there was a shift toward smaller mucins in the COPD group. CONCLUSIONS: Our data indicate that there are differences in mucin amounts and properties between smokers with and without COPD. Further studies are needed to examine how this may impact disease progression.
RATIONALE: Overproduction of mucus is a contributory factor in the progression of chronic obstructive pulmonary disease (COPD). The polymeric mucins are major macromolecules in the secretion. Therefore, we hypothesized that the polymeric mucin composition or properties may be different in the sputum from individuals with COPD and smokers without airflow obstruction. OBJECTIVES: To determine the major polymeric mucins in COPD sputum and whether these are different in the sputum from individuals with COPD compared with that from smokers without airflow obstruction. METHODS: The polymeric mucin composition of sputum from patients with COPD and smokers without airflow obstruction was analyzed by Western blotting analysis. The tissue localization of the mucins was determined by immunohistochemistry, and their size distribution was analyzed by rate-zonal centrifugation. MEASUREMENTS AND MAIN RESULTS:MUC5AC and MUC5B were the major mucins. MUC5AC was the predominant mucin in the smoker group, whereas MUC5B was more abundant from the patients with COPD, with a significant difference in the ratio of MUC5B to MUC5AC (P = 0.004); this ratio was correlated with FEV(1) in the COPD group (r = 0.63; P = 0.01). The lower-charged glycosylated form of MUC5B was more predominant in COPD (P = 0.012). No significant associations were observed with respect to sex, age, or pack-year history. In both groups, MUC5AC was produced by surface epithelial cells and MUC5B by submucosal gland cells. Finally, there was a shift toward smaller mucins in the COPD group. CONCLUSIONS: Our data indicate that there are differences in mucin amounts and properties between smokers with and without COPD. Further studies are needed to examine how this may impact disease progression.
Authors: M P Buisine; L Devisme; M C Copin; M Durand-Réville; B Gosselin; J P Aubert; N Porchet Journal: Am J Respir Cell Mol Biol Date: 1999-02 Impact factor: 6.914
Authors: J R Davies; H W Hovenberg; C J Lindén; R Howard; P S Richardson; J K Sheehan; I Carlstedt Journal: Biochem J Date: 1996-01-15 Impact factor: 3.857
Authors: G Caramori; C Di Gregorio; I Carlstedt; P Casolari; I Guzzinati; I M Adcock; P J Barnes; A Ciaccia; G Cavallesco; K F Chung; A Papi Journal: Histopathology Date: 2004-11 Impact factor: 5.087
Authors: R A O'Donnell; A Richter; J Ward; G Angco; A Mehta; K Rousseau; D M Swallow; S T Holgate; R Djukanovic; D E Davies; S J Wilson Journal: Thorax Date: 2004-12 Impact factor: 9.139
Authors: Kathryn A Ramsey; Alice C H Chen; Giorgia Radicioni; Rohan Lourie; Megan Martin; Amy Broomfield; Yong H Sheng; Sumaira Z Hasnain; Graham Radford-Smith; Lisa A Simms; Lucy Burr; David J Thornton; Simon D Bowler; Stephanie Livengood; Agathe Ceppe; Michael R Knowles; Peadar G Noone; Scott H Donaldson; David B Hill; Camille Ehre; Brian Button; Neil E Alexis; Mehmet Kesimer; Richard C Boucher; Michael A McGuckin Journal: Am J Respir Crit Care Med Date: 2020-03-15 Impact factor: 21.405
Authors: Prescott G Woodruff; Maarten van den Berge; Richard C Boucher; Christopher Brightling; Esteban G Burchard; Stephanie A Christenson; MeiLan K Han; Michael J Holtzman; Monica Kraft; David A Lynch; Fernando D Martinez; Helen K Reddel; Don D Sin; George R Washko; Sally E Wenzel; Antonello Punturieri; Michelle M Freemer; Robert A Wise Journal: Am J Respir Crit Care Med Date: 2017-08-01 Impact factor: 21.405
Authors: Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz Journal: Physiol Rev Date: 2016-10 Impact factor: 37.312
Authors: Ilona Jaspers; Katherine M Horvath; Wenli Zhang; Luisa E Brighton; Johnny L Carson; Terry L Noah Journal: Am J Respir Cell Mol Biol Date: 2009-10-30 Impact factor: 6.914
Authors: Takumi Kiwamoto; Toshihiko Katoh; Michael Tiemeyer; Bruce S Bochner; Christopher M Evans; William J Janssen; Mary E Brummet; Sherry A Hudson; Zhou Zhu Journal: J Allergy Clin Immunol Date: 2014-12-12 Impact factor: 10.793
Authors: Colin D Bingle; Kirsty Wilson; Hayley Lunn; Frances A Barnes; Alec S High; William A Wallace; Doris Rassl; Michael A Campos; Manuel Ribeiro; Lynne Bingle Journal: Histochem Cell Biol Date: 2010-03-18 Impact factor: 4.304